Primary adrenal insufficiency caused by pseudo-neonatal adrenoleukodystrophy associated with biallelic ACOX1 mutations
- 30 April 2025
- journal article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 192 (5) , K38-K43
Abstract
Background: Peroxisomal fatty acyl-CoA oxidase 1, encoded by ACOX1, initiates and limits the rate of beta-oxidation of very long-chain fatty acids (VLCFA). Biallelic ACOX1 mutations cause pseudo-neonatal adrenoleukodystrophy (PNALD). Primary adrenal insufficiency (PAI) has not been clearly characterized in the 34 PNALD patients reported to date. Objective: Characterizing PAI in a patient and her cousin with PNALD. Methods: Clinical data were recorded, and molecular etiologies were investigated using next-generation sequencing panels and 750K microarray. Plasma steroids and VLCFAs were measured via mass spectrometry. Results: A 1.5-year-old female patient was evaluated for PAI due to hyperpigmentation, hypoglycemia, hyponatremia and hyperkalemia. She had a history of severe neonatal-onset hypotonia, seizures, psychomotor/developmental delay, and neurological regression. Molecular studies revealed a homozygous deletion encompassing exons 13 and 14 of the ACOX1 gene. Biochemical analysis revealed accumulation of saturated VLCFA. Cranial magnetic resonance imaging showed T2 high-intensity areas in bilateral centrum semiovale, basal ganglia, brainstem and cerebellar white matter. High plasma ACTH, low cortisol and steroid precursors along with high plasma renin activity were compatible with a PAI other than congenital adrenal hyperplasia (non-CAH). Abdominal computerized tomography demonstrated bilateral adrenal atrophy. The cousin of the patient with PNALD developed non-CAH PAI at 7 months of age. Conclusion: Adrenal insufficiency should be considered in the phenotypic spectrum of peroxisomal disorders. Fatty acyl-CoA oxidase 1 deficiency may emerge as a peroxisomal etiology of non-CAH PAI.Keywords
This publication has 25 references indexed in Scilit:
- Findings from the individualized management of a patient with Acyl-CoA Oxidase-1 (ACOX1) deficiency: A bedside-to-bench-to-bedside strategyMolecular Genetics and Metabolism, 2024
- Acyl CoA oxidase: from its expression, structure, folding, and import to its role in human health and diseaseMolecular Genetics and Genomics, 2023
- Very-long-chain fatty acids induce glial-derived sphingosine-1-phosphate synthesis, secretion, and neuroinflammationCell Metabolism, 2023
- Crystal structures of apo- and FAD-bound human peroxisomal acyl-CoA oxidase provide mechanistic basis explaining clinical observationsInternational Journal of Biological Macromolecules, 2022
- Peroxisomes as cellular adaptors to metabolic and environmental stressTrends in Cell Biology, 2021
- Loss- or Gain-of-Function Mutations in ACOX1 Cause Axonal Loss via Different MechanismsNeuron, 2020
- Primary adrenal insufficiency in children: Diagnosis and managementBest Practice & Research Clinical Endocrinology & Metabolism, 2018
- Evidence of oxidative stress in very long chain fatty acid – Treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteinsNeuroscience, 2012
- Peroxisomal acyl‐CoA‐oxidase deficiency: Two new casesAmerican Journal of Medical Genetics Part A, 2008
- Clinical, biochemical, and mutational spectrum of peroxisomal acyl–coenzyme A oxidase deficiencyHuman Mutation, 2007